Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer
Friedrich, M.
Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
2000
ISSN/ISBN: 0390-6663 PMID: 10968337 Document Number: 519849
Document emailed within 1 workday
Related Documents
Lundin, A.C.; Söderkvist, P.; Eriksson, B.; Bergman-Jungeström, M.; Wingren, S. 1999: Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group Cancer Research 59(10): 2332-2334Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Murphy, B.; Muss, H.B. 1997: Hormonal therapy of breast cancer: state of the art Oncology 11(5 Suppl 4: 7-13
This, P. 2005: Hormonal replacement therapy and breast cancer La Revue du Praticien 55(4): 377-382
Ecker-Schlipf, B. 1994: Anti-hormonal therapy in breast cancer Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Hortobagyi, G.N.; DiStefano, A.; Legha, S.S.; Buzdar, A.U.; Blumenschein, G.R. 1979: Hormonal therapy with tamoxifen in male breast cancer Cancer Treatment Reports 63(4): 539-541
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Lanfranchi, A. 2014: Normal breast physiology: the reasons hormonal contraceptives and induced abortion increase breast-cancer risk Issues in Law and Medicine 29(1): 135-146
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Zhu, Z.R.; Parviainen, M.; Männistö, S.; Pietinen, P.; Eskelinen, M.; Syrjänen, K.; Uusitupa, M. 1995: Vitamin a concentration in breast adipose tissue of breast cancer patients Anticancer Research 15(4): 1593-1596
Johnson, P.A.; Muss, H.; Bonomi, P.; Von Roenn, J.; Wolter, J.; Paschold, E.; Black, W.; Cooper, M. 1988: Megestrol acetate as primary hormonal therapy for advanced breast cancer Seminars in Oncology 15(2 Suppl 1: 34-37
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Saito, K.; Hotta, T.; Kobayashi, S.; Miura, I.; Sakuma, S.; Shimozato, T.; Torii, T.; Iwase, H.; Satake, A.; Nishida, T. 1985: A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy Gan no Rinsho. Japan Journal of Cancer Clinics 31(13): 1727-1730